Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000348764 | SCV000331600 | benign | not specified | 2015-10-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001514281 | SCV001722084 | benign | Kabuki syndrome 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610770 | SCV001841216 | benign | not provided | 2019-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001514281 | SCV001980952 | benign | Kabuki syndrome 2 | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000348764 | SCV004233616 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 33% of patients studied by a panel of primary immunodeficiencies. Number of patients: 31. Only high quality variants are reported. |
Diagnostic Laboratory, |
RCV000348764 | SCV001740655 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000348764 | SCV001799698 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001610770 | SCV001932978 | likely benign | not provided | no assertion criteria provided | clinical testing |